Coherus Oncology (8C5.F) Q2 2025 Earnings

12MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.41
-0.3
-0.19
-0.08

Details

Expected EPS
-0.26800948979999994
Actual EPS
-0.36947559999999996
Surprise EPS
-0.1
Surprise Percent
+37.86%

Description

Coherus Oncology (8C5.F) has reported earnings of -0.36947559999999996 per share for Q2 2025.

0 Comments

Share your thoughts